Position in EXEL
as of Jun 30, 2026
· filed Aug 5, 2026
Position Value
$18,331
-$18,411,072 QoQ
Shares Held
429,690
0.0% QoQ
Ownership
0.173%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
#640
of 739 holders
Holding Since
Sep 2020
24 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in EXEL Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026DekaBank Deutsche Girozentrale holds $3,243,874 across 48 Biotechnology names. EXEL ranks #8 (0.6% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | CAI |
Caris Life Sciences, Inc.
|
146,100 | $2,603,502 | |
| 2 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
506,457 | $225,323 | |
| 3 | REGN |
Regeneron Pharmaceuticals, Inc.
|
211,207 | $157,677 | |
| 4 | BNTX |
BioNTech SE
|
481,397 | $41,203 | |
| 5 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
113,193 | $37,316 | |
| 6 | RPRX |
Royalty Pharma plc
|
746,287 | $35,665 | |
| 7 | JAZZ |
Jazz Pharmaceuticals plc
|
115,130 | $21,009 | |
| 8 | EXEL |
Exelixis, Inc.
This page
|
429,690 | $18,331 |
All Filings in EXEL
Export CSV
24 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $18,331 | 429,690 | Shares | Defined | 2026-08-05 | |
| 2026-03-31 | $18,429,403 | 429,690 | Shares | Defined | 2026-05-07 | |
| 2025-12-31 | $11,103 | 429,690 | Shares | Defined | 2026-01-28 | |
| 2025-09-30 | $17,746,196 | 429,690 | Shares | Defined | 2025-11-03 | |
| 2025-06-30 | $18,940,734 | 429,690 | Shares | Defined | 2025-07-30 | |
| 2025-03-31 | $15,864,154 | 429,690 | Shares | Defined | 2025-04-30 | |
| 2024-12-31 | $14,308,676 | 429,690 | Shares | Defined | 2025-01-29 | |
| 2024-09-30 | $11,150,455 | 429,690 | Shares | Defined | 2024-10-24 | |
| 2024-06-30 | $8,981,033 | 399,690 | Shares | Defined | 2024-08-08 | |
| 2024-03-31 | $10,196,543 | 429,690 | Shares | Defined | 2024-06-04 | |
| 2023-12-31 | $9,118,430 | 380,093 | Shares | Defined | 2024-01-24 | |
| 2023-09-30 | $5,329,193 | 243,899 | Shares | Defined | 2023-11-13 | |
| 2023-06-30 | $4,204,391 | 220,010 | Shares | Defined | 2023-07-25 | |
| 2023-03-31 | $4,107,058 | 211,595 | Shares | Defined | 2023-04-24 | |
| 2022-12-31 | $3,651,008 | 227,619 | Shares | Defined | 2023-02-01 | |
| 2022-09-30 | $3,569,065 | 227,619 | Shares | Defined | 2022-11-02 | |
| 2022-06-30 | $3,543,564 | 170,200 | Shares | Defined | 2022-08-03 | |
| 2022-03-31 | $3,858,434 | 170,200 | Shares | Defined | 2022-04-28 | |
| 2021-12-31 | $1,795,096 | 98,200 | Shares | Defined | 2022-02-02 | |
| 2021-09-30 | $2,018,870 | 95,500 | Shares | Defined | 2021-10-22 | |
| 2021-06-30 | $1,740,010 | 95,500 | Shares | Defined | 2021-08-05 | |
| 2021-03-31 | $2,157,345 | 95,500 | Shares | Defined | 2021-04-28 | |
| 2020-12-31 | $1,916,685 | 95,500 | Shares | Defined | 2021-03-12 | |
| 2020-09-30 | $2,452,335 | 100,300 | Shares | Defined | 2020-10-29 | |
| No filing history on record for this holder in this stock. | ||||||